Corpowell SRL
0.4 FTEThe score of Corpowell shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +78228 % Total assets +1143 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Corpowell's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −506,242 € | ||||
| Equity | €1.76m | ||||
| Cash | 402,186 € | ||||
| EBITDA | −438,162 € | ||||
| Total assets | €3.37m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 05 Sep 2025
- Year ended 31 Dec 2023filed on 25 Aug 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Corpowell's financial analysis
- Solvency52.2%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Corpowell
Corpowell's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0742.572.315
- VAT number
- BE0742572315
- Peppol
- Registered · 0208:0742572315 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jan 2020
- Registered office
- 2000 Antwerp
- Size
- Micro · 0.4 FTE
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Corpowell (SRL) has been based in Antwerp since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 506,242 € and equity of €1.76m; its revenue is not published. With 0.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 52.2%, above the median of its sector (45.8%).
Companies similar to Corpowell
Companies in the same business, of comparable size and area, outside its group.
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- Orthophysics Manufacture of medical and dental instruments and supplies Hooglede · balance sheet €2.78m
- Aagato Medical Wholesale of pharmaceutical and medical goods Ghent · balance sheet €3.86m
- ERC Pharma Wholesale of pharmaceutical and medical goods Gembloux · balance sheet €3.56m
- Contipharma Wholesale of pharmaceutical and medical goods Seraing · balance sheet €7.21m
- Medisphere Wholesale of pharmaceutical and medical goods Hamois · balance sheet €6.04m
- Z-Projects Wholesale of pharmaceutical and medical goods Zandhoven · balance sheet €1.31m
- Cornette An Retail sale of pharmaceutical products Steenokkerzeel · balance sheet €5.25m
Frequently asked questions about Corpowell
What is the revenue of Corpowell?
Corpowell files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Corpowell?
In Belgium, the VAT number is the company number prefixed with BE: BE0742572315 for Corpowell, if the company is VAT-registered. Its company number (CBE) is 0742.572.315.
Where is the registered office of Corpowell?
According to the CBE register, the registered office of Corpowell is in 2000 Antwerp.
What is the equity of Corpowell?
At the close of the 2025 financial year, the equity of Corpowell amounts to 1,762,297 €, a solvency of 52.2% of total assets.
How many people work at Corpowell?
0.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Corpowell?
The register lists 7 active mandates at Corpowell. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Corpowell
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →